Efstratios Vakirlis
Aristotle University of Thessaloniki
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Efstratios Vakirlis.
Journal of The European Academy of Dermatology and Venereology | 2011
Efstratios Vakirlis; Elizabeth Lazaridou; Thrasivoulos Tzellos; S. Gerou; Dimitrios Chatzidimitriou; D. Ioannides
Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with increasing frequency over the last decades, especially in adults. Cytokines orchestrate atopic skin inflammation.
Therapeutics and Clinical Risk Management | 2008
Efstratios Vakirlis; Athanasios Kastanis; Demetrios Ioannides
Psoriasis is one of the most common skin diseases. The mainstay of treatment for the vast majority of patients is topical therapy. A rising first-line treatment modality for psoriasis vulgaris is the two-compound ointment containing calcipotriol 50 μg/g plus betamethasone dipropionate 0.5 mg/g (Dovobet®, Daivobet®, Taclonex®), which combines a vitamin D analog and a corticosteroid. This innovative formulation preserves the activity and bioavailability of the two components and many clinical studies have demonstrated that it has a greater efficacy, tolerability, and a rapid onset of action compared with its individual ingredients or tacalcitol.
Journal of The European Academy of Dermatology and Venereology | 2013
Elizabeth Lazaridou; A. Tsikrikoni; Christina Fotiadou; E. Kyrmanidou; Efstratios Vakirlis; C. Giannopoulou; Z. Apalla; D. Ioannides
Background Both chronic plaque psoriasis and periodontitis have an increasing prevalence worldwide and have been associated with the metabolic syndrome; however limited information is available on their association.
Journal of The European Academy of Dermatology and Venereology | 2017
Elena Sotiriou; Z. Apalla; F. Vrani; Elizabeth Lazaridou; Efstratios Vakirlis; A. Lallas; D. Ioannides
Individuals with medical history of non‐melanoma skin cancers (NMSCs) usually develop multiple and/or recurrent malignant lesions around the site of the primary neoplasm. The latter represents the clinical expression of the ‘field cancerization’ theory; supporting the presence of multiple malignant clones of dysplastic keratinocytes over the entire epithelium that potentially can progress into clinical lesions. Taking into consideration that the burden of NMSCs on public health and health‐care cost is high, adequate control of recurrences and management of field change is challenging.
Journal of Cutaneous Medicine and Surgery | 2015
Christina Fotiadou; Elizabeth Lazaridou; Eleni Sotiriou; Spiridon Gerou; Athanasios Kyrgidis; Efstratios Vakirlis; D. Ioannides
Introduction: T-helper 1 (Th1), Th17 cells, and their related cytokines are implicated in psoriasis pathogenesis although the contribution of each group of cytokines in psoriasis activity has not been fully clarified. Objectives: To investigate whether Th17-related cytokines are associated with psoriasis activity. Methods: The serum levels of interleukin (IL)-1β, 6, 8, 17Α, 22, 23, and tumor necrosis factor-α (TNFα) were measured with flow cytometry in 35 patients with plaque psoriasis (21 with stable and 14 with active disease) and in 20 healthy controls. Results: Interleukin-6, 8, 17A, 22, 23, and TNFα were significantly elevated in psoriasis patients compared with controls. In the sensitivity analyses, patients with active disease showed significantly increased levels of IL-17A, IL-23, and IL-22 as compared to the group of patients with stable psoriasis. Conclusions: Our study highlights a possible crucial role of IL-17A, IL-22, and IL-23 in the activity of psoriasis and the early stages of the disease.
Journal of The European Academy of Dermatology and Venereology | 2018
Elena Sotiriou; G. Evangelou; Evangelia Papadavid; Z. Apalla; F. Vrani; Efstratios Vakirlis; M. Panagiotou; M. Stefanidou; T. Pombou; K. Krasagakis; Dimitris Rigopoulos; D. Ioannides
Daylight PDT (DLPDT) is a new PDT procedure. Several trials demonstrate that DLPDT achieves similar response rates with conventional PDT (CPDT) in the treatment of non‐hyperkeratotic actinic keratoses (AKs) in a nearly painless way. It seems that DLPDT represents a more convenient and equally effective treatment modality. Data on long‐term efficacy of DLPDT are limited.
Clinical, Cosmetic and Investigational Dermatology | 2017
Zoe Apalla; Chrysoula Papageorgiou; Aimilios Lallas; Elena Sotiriou; Elizabeth Lazaridou; Efstratios Vakirlis; Athanassios Kyrgidis; Demetrios Ioannides
Vismodegib is approved for the treatment of adult patients with metastatic (mBCC) or locally advanced basal cell carcinoma (laBCC) that have recurred following surgery or for those who are not good candidates for surgery (risk/benefit ratio is against patient’s benefit, either because of the general condition or because of the expected morbidity from the surgery) or radiation therapy. This article provides an evidence-based review of its current place in therapy. Analytically, the clinical implications in the management of laBCCs and mBCCs and possible new indications, including the neoadjuvant use before surgical excision, are discussed, while in the end, the challenges regarding class-related adverse events and their optimal management are highlighted.
Journal of The European Academy of Dermatology and Venereology | 2016
Zoe Apalla; Aimilios Lallas; Eleni Sotiriou; Elizabeth Lazaridou; Efstratios Vakirlis; M. Trakatelli; Athanassios Kyrgidis; Demetrios Ioannides
Ultraviolet radiation plays an important role in the pathogenesis of non‐melanoma skin cancer. Outdoor workers, including farmers, experience higher exposure levels compared to the general population. Available literature data suggest that occupational ultraviolet exposure represents an independent risk factor for squamous cell carcinoma; whereas for basal cell carcinoma (BCC) this association still remains unclarified.
Annals of Surgical Oncology | 2006
Alexander Dionyssopoulos; Ioanna Mandekou-Lefaki; Efstratios Vakirlis; Ioannis Manoliadis; Andreas Nikolis; Eleni Dionyssopoulou
BackgroundExtramammary Paget’s disease is a rare cutaneous malignancy, which occurring frequently in the elderly and affecting primarily the genital, perianal, and axillary regions. Unfortunately, surgical and ablative treatment modalities for extramammary Paget’s disease have a high recurrence rate and are often associated with significant morbidity.MethodsWe present a case of a 51-year-old Caucasian man with Paget’s disease of the right groin. The isolated localization of Paget’s disease in the groin is extremely rare. Wide local excision of the tumor is currently the standard of care treatment. All publications found in the literature reporting this rare entity were reviewed for the purpose of further delineating a treatment regimen for this rare pathology.ResultsSix years after surgery, the patient remains disease free with a very acceptable aesthetic result. Currently, only 11 cases of Paget’s disease have been reported with an isolated localization to the groin.ConclusionsPaget’s disease of the groin has an extremely low incidence. Various treatments are described in the literature, early wide local excision may be the treatment of choice.
Rheumatology International | 2018
Anastasia Skalkou; Sofia-Magdalini Manoli; Alexandros Sachinidis; Vasilios Ntouros; Konstantinos Petidis; Eleni Pagkopoulou; Efstratios Vakirlis; Athina Pyrpasopoulou; Theodoros Dimitroulas
Rheumatoid arthritis is a systemic autoimmune disease resulting in joint destruction and deformities, but also associated with extraarticular and systemic manifestations. The later devastating conditions, such as the development of rheumatoid vasculitis, are more frequently encountered in seropositive patients and their incidence has been attenuated after the introduction of biologic disease modifying drugs, such as anti-tumor necrosis factor alpha (TNFa) agents, which generally have considerably contributed to the better control and long-term outcomes of the disease. Interestingly, autoimmune syndromes may, rarely, present in patients without a positive history after the initiation of treatment. We present a rare case of a woman with seronegative rheumatoid arthritis who developed pyoderma gangrenosum whistle on treatment with golimumab, a fully humanized anti TNFa antibody. The recording of this as well as analogous paradoxical autoimmune syndromes in association with the individual patient characteristics will render treating physicians aware of potential adverse reactions and assist in the understanding of the cytokine driven pathophysiological mechanisms underlying these disorders.